Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06657833

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Led by Fundación EPIC · Updated on 2026-02-12

128

Participants Needed

12

Research Sites

149 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

International, investigator-driven, multicenter, open-label, prospective randomized controlled trial where patients with de novo lesions due to calcified nodules (CN) were randomized to drug eluting balloon (DEB) or drug eluting stents (DES).

CONDITIONS

Official Title

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years old with stable coronary artery disease or acute coronary syndromes needing PCI
  • Severe coronary lesion with calcified nodule confirmed by optical coherence tomography or intravascular ultrasound
  • Lesion located in a vessel between 2.5 and 4 mm in diameter
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide informed consent or attend follow-up angiographic visits
  • Pregnant or breastfeeding
  • Cardiogenic shock or cardiac arrest during the initial procedure
  • Unable to maintain double antiplatelet therapy for at least 1 month
  • Life expectancy less than 1 year
  • Lesion located at the left main stem
  • Aorto-ostial lesion
  • Target lesion previously treated with stents or drug eluting balloon
  • High thrombus burden in the target lesion (TIMI thrombus scale 3 or higher)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 12 locations

1

Hospital Del Mar

Barcelona, Spain, 08003

Actively Recruiting

2

Hospital Universitario de La Paz

Fuencarral-El Pardo, Spain, 28046

Actively Recruiting

3

Hospital Universitario de Galdakao-Usansolo

Galdakao, Spain, 48960

Actively Recruiting

4

Hospital Universitario de León

León, Spain, 24008

Actively Recruiting

5

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041

Actively Recruiting

6

Hospital Universitario Puerta de Hierro

Madrid, Spain, 28222

Actively Recruiting

7

Hospital Clínico San Carlos

Moncloa-Aravaca, Spain, 28040

Actively Recruiting

8

Hospital Universitario de Navarra

Pamplona, Spain, 31008

Actively Recruiting

9

Hospital General Universitario de Valencia

Valencia, Spain, 46014

Actively Recruiting

10

Hospital Universitario y Politécnico La Fe

Valencia, Spain, 46026

Actively Recruiting

11

Hospital Clínico Universitario de Valladolid

Valladolid, Spain, 47003

Actively Recruiting

12

Hospital Universitario de Vigo

Vigo, Spain, 36312

Actively Recruiting

Loading map...

Research Team

F

FUNDACION EPIC

CONTACT

A

ALFONSO JURADO ROMAN, MD,PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy. | DecenTrialz